Study of P53 Gene Alteration as a Biomarker to Evaluate the Malignant Risk of Lugol-Unstained Lesion With Non-Dysplasia in the Oesophagus

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6603582
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

23. P53 IN BARRETT’S Oesophagus With Changes Indefinite for Dysplasia

Pathology
Forensic MedicinePathology
2020English

Risk of Malignant Progression in Patients With Barrett's Oesophagus: A Dutch Nationwide Cohort Study

Gut
Gastroenterology
2010English

Vertebral Height as the Measure of Lesion Length in Carcinoma of the Oesophagus - Is It Accurate?

South African Journal of Radiology
RadiologicalRadiologyNuclear MedicineUltrasound TechnologyImaging
2004English

Rising Death Rate From Non-Malignant Disease of the Oesophagus (NMOD) in England and Wales.

Gut
Gastroenterology
1995English

Souttar Tube for Malignant Stricture of the Oesophagus

2020English

Expression of the P53 Homologue P63alpha and DeltaNp63alpha in the Neoplastic Sequence of Barrett's Oesophagus: Correlation With Morphology and P53 Protein

Gut
Gastroenterology
2001English

Atomic Force Microscopy as a Tool to Evaluate the Risk of Cardiovascular Diseases in Patients

Biophysical Journal
Biophysics
2017English

Association Study of TAAAA Polymorphism in the First Intron of P53 Gene With Risk of Colorectal Cancer in Iranian Population

Egyptian Journal of Medical Human Genetics
Genetics
2019English

A Case of Polyostotic Fibrous Dysplasia With Hemangioma-Like Lesion

Orthopedics & Traumatology
1978English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy